Cyprus announces the approval of the COVID-19 vaccine administered for children ages 5 to 11 years and also allowing adults to receive booster dose two weeks sooner than…
Cyprus announces the approval of the COVID-19 vaccine administered for children ages 5 to 11 years and also allowing adults to receive booster dose two weeks sooner than six months after their second dose in order to curb the rise of COVID-19 cases following the first case of the SARS-CoV-2 Omicron variant.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthCyprus announces the approval of the COVID-19 vaccine administered for children ages 5 to 11 years and also allowing adults to receive booster dose two weeks sooner than…
View Premium plansBrowse free archive reportsCyprus announces the approval of the COVID-19 vaccine administered for children ages 5 to 11 years and also allowing adults to receive booster dose two weeks sooner than six months after their second dose in order to curb the rise of COVID-19 cases following the first case of the SARS-CoV-2 Omicron variant.